Powder and Yahoo may earn commission from links in this article.
Voters are frustrated by home prices, and the Senate will soon take up the bipartisan 21st Century ROAD to Housing Act. But the bill is a 300-page melange of federal grants and pilot programs, plus a ...
Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. This voice experience is generated by AI. Learn more.
INDIANAPOLIS — Indiana Governor Mike Braun is promising that relief is on the way for your energy costs. During a press conference Monday, Braun argued that his new strategy to hold utility companies ...
The FDA has put a partial clinical hold on PepGen’s phase 2 muscle wasting trial after reviewing preclinical data, continuing the stop-start advance of the program. Guggenheim Securities analysts ...
Isaac Hayes’ estate has reached a private settlement with Donald Trump after suing the president and his campaign over the unauthorized use of the 1966 soul classic “Hold On, I’m Coming” at campaign ...
Michael Cancelleri, an entrepreneur in San Clemente, Calif., has poured tens of thousands of dollars into his son’s baseball career—club team fees, tournament travel and top-of-the-line equipment. As ...
Polo Rocha has written about economics and banking for a decade. Kevin Dietsch / Getty Images Inflation rose to 3% in December, prompting the Federal Reserve to pause further interest rate cuts.
Nvidia will benefit for years to come from its leading position in AI processors. Alphabet's Google Gemini is gaining ground, and recent Google Cloud revenue shows the company knows how to monetize AI ...
Sen. Thom Tillis (R-N.C.), a senior member of the Senate Banking Committee, says he will continue holding up President Trump’s nominees to the Federal Reserve until the criminal investigation of Fed ...
For her feature debut, director Myrsini Aristidou treads in familiar waters, but her astute writing and assuredly bittersweet performances take the story into singular, surprising places. “Hold Onto ...
Jan 28 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Wednesday the U.S. Food and Drug Administration has placed a clinical hold on two of its experimental gene therapy programs for rare ...